ARTICLE | Company News
Angiotech, Broncus deal
June 6, 2005 7:00 AM UTC
ANP granted Broncus a worldwide, non-exclusive license to use paclitaxel technology with Broncus' Exhale system to treat emphysema and other diseases related to chronic obstructive pulmonary disorder ...